THE Food and Drug Administration on Monday approved a drug called baricitinib as the first oral tablet for treating severe alopecia areata, an autoimmune disorder affecting more than 300,000 people in the United States every year.
Alopecia causes either temporary or permanent patchy hair loss that can affect any hair-bearing site of the body, leading to emotional distress. The condition has come to the fore recently through high-profile cases including Hollywood actress Jada Pinkett Smith and congresswoman Ayanna Pressley.
"Access to safe and effective treatment options is crucial for the significant number of Americans affected by severe alopecia," said FDA official Kendall Marcus in a statement.
"Today's approval will help fulfill a significant unmet need for patients with severe alopecia areata."
Baricitinib, which is made by US pharmaceutical company Eli Lilly and known by the trade name Olumiant, belongs to a class of drugs called Janus kinase inhibitors. It works by interfering with the cellular pathway that leads to inflammation.
Its approval for use against alopecia was based on the results of two randomized, controlled clinical trials involving a total 1,200 adults with severe alopecia.
Each trial split participants into three groups: a placebo group, a group that received a two-milligram dose every day, and a group that received a four-milligram dose every day.
After 36 weeks, almost 40 percent of those on the higher dose grew back 80 percent of their scalp hair, compared to around 23 percent of the lower dose group, and five percent of the placebo group.
Around 45 percent of people in the higher dose group also saw significant eyebrow and eyelash regrowth.
The most common side effects included upper respiratory tract infections, headaches, acne, high cholesterol, and increase of an enzyme called creatine phosphokinase.
Prior treatments for alopecia included topical or oral drugs, but these have been considered experimental and none was approved.
Baricitinib was previously approved for treatment of rheumatoid arthritis, and during the Covid pandemic its license was extended to the treatment of hospitalized Covid patients.
ETX Studio
Wed Jun 15 2022
Alopecia has come to the fore recently through high-profile cases including Hollywood actress Jada Pinkett Smith. - ETX Studio
Menjelang setahun serangan Israel, Rosco anjur konvoi solidariti untuk Gaza
Rosco menganjurkan konvoi motorsikal jenis Cafe Racer di sekitar Lembah Klang sebagai tanda solidariti perjuangan rakyat Palestin.
'Masa untuk hentikan penderitaan' - Ketua PBB rayu keamanan
Antonio Guterres membuat rayuan untuk keamanan menjelang ulang tahun pertama konflik di Gaza minggu depan.
Larian berpakaian tidak senonoh: Tiga lelaki ditahan bantu siasatan
Dua lelaki warga asing dan seorang warga tempatan berusia antara 39 hingga 70 tahun ditahan di sebuah hotel di Kota Tinggi.
Wanita Palestin mengamuk di WTKL mohon maaf, tertekan fikir anak di Gaza
Aminah berkata, perbuatan di luar kawalan itu berlaku disebabkan rasa tertekan memikirkan keadaaan anaknya yang masih berada di Gaza.
Mangsa banjir di Perak terus meningkat, Selangor menurun
Jumlah mangsa banjir yang ditempatkan di PPS di Perak terus meningkat pagi ini manakala jumlah mangsa di Selangor menunjukkan penurunan.
Letupan baharu menggegarkan Beirut
Memetik laporan Associated Press, rejim Zionis turut menyerang kem pelarian Palestin jauh di utara buat kali pertama ketika ia menyasarkan kedua-dua pejuang Hezbollah dan Hamas.
Pelabur makin yakin, Malaysia disaran tingkatkan keperluan RE
Keperluan tenaga boleh baharu (RE) di negara ini semakin meningkat seiring keyakinan pelabur asing khususnya untuk mewujudkan pusat data, kata Timbalan Perdana Menteri, Datuk Seri Fadillah Yusof.
Dua minggu hilang, nasib Orang Asli Zuzina masih misteri
Pelbagai pihak masih mencari wanita orang Asli Zuzina Abine yang hilang selepas keluar rumah sejak 20 September lalu.
Ringgit dijangka berbanding dolar AS minggu depan
Ringgit dijangka kekal pada paras 4.21 hingga 4.22 berbanding dolar AS minggu depan, tetapi dengan kecenderungan meningkat terhadap dolar AS selepas data senarai gaji bukan ladang (NFP) Amerika Syarikat (AS) bagi September meningkat mendadak kepada 254,000 pekerjaan.
[TERKINI] Enam rakyat Malaysia selamat tiba dari Lubnan pagi ini
Kementerian Luar Negeri mengesahkan seramai enam orang rakyat Malaysia daripada sebuah keluarga selamat tiba di Lapangan Terbang Antarabangsa Kuala Lumpur (KLIA) dari Lubnan pada pagi ini (6 Oktober 2024).
KKM guna Baricitinib rawat pesakit COVID-19 kategori empat dan lima
Hospital seluruh negara akan mula menggunakan ubat Baricitinib untuk rawatan kepada pesakit COVID-19 terutama pesakit kategori empat dan lima.
KKM akan guna Baricitinib cegah peralihan pesakit COVID-19 ke kategori lebih meruncing
Kementerian Kesihatan (KKM) akan menggunakan ubat Baricitinib bagi mengelakkan peningkatan atau peralihan pesakit COVID-19 ke kategori yang lebih meruncing.